ID

29869

Descripción

Study ID: 102587 Clinical Study ID: EGF102587 Study Title: A Single-Dose, Open-Label, Randomized, Three-Way Cross-Over Study in Healthy Subjects to Evaluate the Relative Bioequivalence of Two New Small Tablet Formulations of Lapatinib (GW572016) Patient Level Data: Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: lapatinib Trade Name: Tykerb,Tycerb,Tyverb; Tyverb,Tykerb,Tycerb Study Indication: Neoplasms, Breast Documentation part: Serious Adverse Event, Relevant Concomitant Treatment/Medications/Results

Palabras clave

  1. 24/4/18 24/4/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

24 de abril de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

GSK Study to Evaluate the Relative Bioequivalence of Two New Small Tablet Formulations of Lapatinib in Healthy Subjects 102587

Serious Adverse Event, Relevant Concomitant Treatment/Medications/Results

Relevant concomitant / treatment medications
Descripción

Relevant concomitant / treatment medications

Alias
UMLS CUI-1
C2347852
UMLS CUI-2
C0087111
UMLS CUI-3
C1519255
CM Sequence Number
Descripción

CM Sequence Number

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348184
Drug name
Descripción

(Trade Name preferred)

Tipo de datos

text

Alias
UMLS CUI [1]
C2360065
Dose
Descripción

Dose

Tipo de datos

text

Alias
UMLS CUI [1]
C3174092
Unit
Descripción

units of medication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C2347852
Frequency
Descripción

Frequency

Tipo de datos

text

Alias
UMLS CUI [1]
C3476109
Route
Descripción

Route of medication

Tipo de datos

text

Alias
UMLS CUI [1]
C0013153
Start Date
Descripción

Start Date

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0808070
Ongoing?
Descripción

Ongoing medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826666
If no ongoing medication, specify end date
Descripción

End date medication

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0806020
Primary Indication
Descripción

Primary Indication

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3146298
Drug Type
Descripción

Drug Type

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0457591
UMLS CUI [1,2]
C2347852
Relevant medical conditions/Risk factors
Descripción

Relevant medical conditions/Risk factors

Alias
UMLS CUI-1
C0262926
UMLS CUI-2
C0035648
UMLS CUI-3
C1519255
MHx Sequence Number
Descripción

MHx Sequence Number

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348184
Specific Condition Name
Descripción

Specific Condition Name

Tipo de datos

text

Alias
UMLS CUI [1]
C0012634
Date of onset
Descripción

Date of onset

Tipo de datos

date

Alias
UMLS CUI [1]
C0574845
Specific Condition Continuing?
Descripción

Specific Condition Continuing

Tipo de datos

integer

Alias
UMLS CUI [1]
C0012634
Specific Condition Continuing? If No, specify date of last occurrence
Descripción

Date of last occurrence

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2745955
UMLS CUI [1,2]
C0012634
UMLS CUI [1,3]
C0011008
Relevant medical conditions/Risk factors not noted above
Descripción

Relevant medical conditions/Risk factors

Tipo de datos

text

Alias
UMLS CUI [1]
C0262926
UMLS CUI [2]
C0035648
Relevant diagnostic results
Descripción

Relevant diagnostic results

Alias
UMLS CUI-1
C0430022
UMLS CUI-2
C0456984
UMLS CUI-3
C1519255
Lab Sequence Number
Descripción

Lab Sequence Number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0022885
UMLS CUI [1,2]
C2348184
Test Name
Descripción

Test Name

Tipo de datos

text

Alias
UMLS CUI [1]
C0022885
Test Date
Descripción

Test Date

Tipo de datos

date

Alias
UMLS CUI [1]
C2826641
Test Result
Descripción

Test Result

Tipo de datos

text

Alias
UMLS CUI [1]
C0587081
Test Units
Descripción

Test Units

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C0587081
Normal Low Range
Descripción

Normal Low Range

Tipo de datos

text

Alias
UMLS CUI [1]
C0086715
Normal High Range
Descripción

Normal High Range

Tipo de datos

text

Alias
UMLS CUI [1]
C0086715
Relevant diagnostic results not noted above
Descripción

Relevant diagnostic results not noted above

Tipo de datos

text

Alias
UMLS CUI [1]
C0587081
If investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?
Descripción

event recurrence

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C0034897

Similar models

Serious Adverse Event, Relevant Concomitant Treatment/Medications/Results

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Relevant concomitant / treatment medications
C2347852 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
CM Sequence Number
Item
CM Sequence Number
integer
C2348184 (UMLS CUI [1])
Drug name
Item
Drug name
text
C2360065 (UMLS CUI [1])
Dose
Item
Dose
text
C3174092 (UMLS CUI [1])
units of medication
Item
Unit
text
C1519795 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Frequency
Item
Frequency
text
C3476109 (UMLS CUI [1])
Route of medication
Item
Route
text
C0013153 (UMLS CUI [1])
Start Date
Item
Start Date
date
C2347852 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
Ongoing medication
Item
Ongoing?
boolean
C2826666 (UMLS CUI [1])
End date medication
Item
If no ongoing medication, specify end date
date
C2347852 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Primary Indication
Item
Primary Indication
text
C2347852 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
Drug Type
Item
Drug Type
text
C0457591 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item Group
Relevant medical conditions/Risk factors
C0262926 (UMLS CUI-1)
C0035648 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
MHx Sequence Number
Item
MHx Sequence Number
integer
C2348184 (UMLS CUI [1])
Specific Condition Name
Item
Specific Condition Name
text
C0012634 (UMLS CUI [1])
Date of onset
Item
Date of onset
date
C0574845 (UMLS CUI [1])
Item
Specific Condition Continuing?
integer
C0012634 (UMLS CUI [1])
Code List
Specific Condition Continuing?
CL Item
Yes (1)
CL Item
No, specify date of last occurrence  (2)
CL Item
Unknown (3)
Date of last occurrence
Item
Specific Condition Continuing? If No, specify date of last occurrence
date
C2745955 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Relevant medical conditions/Risk factors
Item
Relevant medical conditions/Risk factors not noted above
text
C0262926 (UMLS CUI [1])
C0035648 (UMLS CUI [2])
Item Group
Relevant diagnostic results
C0430022 (UMLS CUI-1)
C0456984 (UMLS CUI-2)
C1519255 (UMLS CUI-3)
Lab Sequence Number
Item
Lab Sequence Number
text
C0022885 (UMLS CUI [1,1])
C2348184 (UMLS CUI [1,2])
Test Name
Item
Test Name
text
C0022885 (UMLS CUI [1])
Test Date
Item
Test Date
date
C2826641 (UMLS CUI [1])
Test Result
Item
Test Result
text
C0587081 (UMLS CUI [1])
Test Units
Item
Test Units
text
C1519795 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Normal Low Range
Item
Normal Low Range
text
C0086715 (UMLS CUI [1])
Normal High Range
Item
Normal High Range
text
C0086715 (UMLS CUI [1])
Relevant diagnostic results not noted above
Item
Relevant diagnostic results not noted above
text
C0587081 (UMLS CUI [1])
Item
If investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?
integer
C0877248 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0034897 (UMLS CUI [1,3])
Code List
If investigational product(s) were stopped temporarily, did the reported event(s) recur after investigational products were restarted?
CL Item
No (1)
CL Item
Yes (2)
CL Item
Unknown at this time (3)
CL Item
Not applicable (4)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial